Search - Archive ouverte HAL Access content directly

Filter your results

5 Results
authFullName_s : A. Renneville

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

C. Bally , L. Ades , A. Renneville , M. Sebert , V. Eclache et al.
LEUKEMIA RESEARCH, 2014, 38 (7), pp.751-5. ⟨10.1016/j.leukres.2014.03.012⟩
Journal articles hal-03653835v1

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

C. Willekens , O. Blanchet , A. Renneville , P. Cornillet-Lefebvre , C. Pautas et al.
Haematologica, 2016, 101 (3), pp.328 - 335. ⟨10.3324/haematol.2015.131946⟩
Journal articles inserm-01817446v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1
Image document

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Andrea Toma , O. Kosmider , S. Chevret , J. Delaunay , A. Stamatoullas et al.
Leukemia, 2016, 30 (4), pp.897--905. ⟨10.1038/leu.2015.296⟩
Journal articles hal-01321412v1